Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

NCT01272804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
NIDDM

Interventions

DRUG: PF-04937319
DRUG: Placebo

Sponsor

Pfizer